gene_symbol
MS4A1
hgnc_id
HGNC:7315
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Obinutuzumab binds CD20 on B cells, inducing direct cell death and recruiting immune effectors via FcγRIIIa for enhanced ADCC/ADCP, with some complement-mediated cytotoxicity (CDC).
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Type II anti-CD20 epitope; primary tumor antigen on B cells
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06592170
disease_id_num_tar_ref
4461
drug_id_num_tar_ref
12055